ATLANTA, 08/07/2018 -- The Lewy Body Dementia Association (LBDA) is proud to announce the appointment of Emily N. Pualwan, CEO and Executive Director of HazingPrevention.Org, to its board of directors.
“We are pleased to welcome Emily to the LBDA Board of Directors. She will be a great asset to our growing and evolving organization. We are excited to have her join our team,” Tina Christie, President, Board of Directors.
Pualwan brings with her 30 years of experience in nonprofit management, including leadership roles at the American Cancer Society where she also served as the Vice President of their advocacy sister organization, American Cancer Society Cancer Action Network (ACSCAN).
Her expertise includes extensive experience in publishing, media, advocacy, and public policy in both healthcare and higher education. She has held publishing roles in the UK and the US and has edited and published more than 20 books and articles.
As an anti-hazing, cancer, and substance abuse expert, Emily has appeared on the Today Show and NBC Nightly News and served as subject matter lead for BBC World Service documentary, ABC News Radio, and in print media.
Pualwan has a B.A. in philosophy and logic from Bates College and studied analytic philosophy and the logic of language at the University of Oxford.
With the appointment of Pualwan, LBDA’s board of directors consists of eight members, including: Christina M/ Christie, Board President, CRC Industries, Inc.; Shannon McCarty-Caplan, Board Vice President, ReachLocal; Andy Matteis, Board Treasurer, Global Equity Research; Marshall Cannon, Board Secretary, Delta Dental of California; Todd Graham, Vice President of the Executive Committee, CoMeg Partners, LLC; James Galvin, M.D., Director, Charles E. Schmidt College of Medicine at Florida Atlantis University; Nick Williams, Director, PruittHealth.
About the Lewy Body Dementia Association
The Lewy Body Dementia Association is the nation’s leading authority on Lewy body dementias (LBD) and is dedicated to continuous outreach, education, research, and support for those affected with LBD and their families. LBD is a progressive brain disease that affects thinking, movement, behavior, and impacts 1.4 million people in the United States.